Home > Products > Human Tumor Cell Lines >
SN12C | ||||
---|---|---|---|---|
Product Name | SN12C | |||
Price | Get Quote | |||
Product Code | SN-12C | |||
Cat.No | ABC-TC1055 | Species | Human | |
Size/Quantity | 1 vial | Biosafety Level | 1 | |
Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
Description | Tumorigenecity: Isoenzyme: Histopathology: carcinoma, renal cellSubculture: Split ratio: Media change: Reverse transcritase: Production. | |||
Stock | Out of stock | |||
Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). White, S., Avantaggiati, M., Nemazanyy, I., Di Poto, C., Yang, Y., & Pende, M. et al. (2019). YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells. Developmental Cell, 49(3), 425-443.e9. https://doi.org/10.1016/j.devcel.2019.04.014 | |||
Application | For research use only | |||
Growth Conditions | 37 ℃, 5% CO2 | |||
Product Type | Human Kidney Cancer Cell Lines | |||
Product Image |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.